Common Equity (Annual)

Common Equity: The sum of all common equity items.

Amphastar Pharmaceuticals, Inc. (AMPH) had Common Equity of $788.80M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$719.89M
Net Income	$98.09M
Cost of Goods Sold	$363.83M
Gross Profit	$356.06M
Operating Expenses	$579.48M
Operating Income	$140.40M
Non-Operating Income/Expense	$-16.78M
Pre-Tax Income	$123.62M
Normalized Pre-Tax Income	$123.62M
Income after Taxes	$98.09M
Income from Continuous Operations	$98.09M
Consolidated Net Income/Loss	$98.09M
Normalized Income after Taxes	$98.09M
EBIT	$140.40M
EBITDA	$200.45M
Weighted-Average Shares Outstanding (Basic)	46.74M
Weighted-Average Shares Outstanding (Diluted)	48.22M
Earnings per Share (EPS) (Basic)	$2.10
Earnings per Share (EPS) (Diluted)	$2.03
Balance Sheet Financials
Current Assets	$636.02M
Property, Plant, and Equipment	$310.57M
Long-Term Assets	$993.28M
Total Assets	$1.63B
Current Liabilities	$158.16M
Long-Term Debt	$608.75M
Long-Term Liabilities	$682.34M
Total Liabilities	$840.49M
Common Equity	$788.80M
Tangible Shareholders Equity	$222.84M
Shareholders Equity	$788.80M
Common Shares Outstanding	45.65M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$156.12M
Cash Flow from Investing Activities	$-70.33M
Cash Flow from Financial Activities	$-67.42M
Beginning Cash	$151.84M
End Cash	$170.41M
Increase/Decrease in Cash	$18.57M
Stock-Based Compensation	$27.28M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.02
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.44
Debt to Equity Ratio	0.77
Gross Margin	49.46%
Operating Margin	19.50%
EBIT Margin	19.50%
EBITDA Margin	27.85%
Pre-Tax Profit Margin	17.17%
Profit Margin	13.63%
Free Cash Flow	$121.23M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.44
Inventory Turnover	2.06
Receiveable Turnover	4.48
Days Sales in Receivables	81.49
Return on Equity	12.44%
Return on Tangible Equity	44.02%
Return on Assets	6.02%
Return on Investments	7.02%
Book Value Per Share	$17.28
Free Cash Flow per Share	$2.51
Operating Cash Flow per Share	$3.24

Data from Zacks Investment Research, Inc.